Managed entry agreements: lessons from European payers

Marie-France Courriol, Brian Godman

Research output: Contribution to journalComment/debate

80 Downloads (Pure)

Abstract

At the pharmaccess leaders forum organised by nextlevel pharam in London in April 2018, Brian Godman, senior resarcher at the Stockholm Karolinska Institute, and Professor affiliated to several universities (including the university of Strathclyde, Glasgow), presented an overview of managed entry agreements (MEAs) for high-cost drugs from the niewpoint of Eurpean reimbursement agencies. He offered coference delegates insights into what pharmaceutical companies can do to conclude successful MEAs. Following the meering, he spoke to Marie-France Courriol for PPR.
Original languageEnglish
Number of pages5
JournalIMS Pharma Pricing & Reimbursement
Publication statusPublished - 1 Jul 2018

Keywords

  • managed entry agreements
  • pharmacoeconomics
  • pharmaceutical companies
  • healthcare costs

Cite this